167 related articles for article (PubMed ID: 6889879)
1. Plasma concentrations of isosorbide dinitrate and mononitrates after acute and chronic oral administration of isosorbide dinitrate in man.
Bruyneel K; Rosseel MT; Bogaert MG
Arzneimittelforschung; 1982; 32(7):769-73. PubMed ID: 6889879
[TBL] [Abstract][Full Text] [Related]
2. Single administration of atenolol does not influence the kinetics of orally given isosorbide dinitrate.
Bogaert MG; Rosseel MT; Bruyneel K
Int J Clin Pharmacol Res; 1983; 3(6):491-3. PubMed ID: 6678835
[TBL] [Abstract][Full Text] [Related]
3. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
Laufen H; Aumann M; Leitold M
Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of isosorbide dinitrate and the isosorbide mononitrates after increasing doses of a retard preparation of isosorbide dinitrate.
Bogaert MG; Rosseel MT
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2424-7. PubMed ID: 7422532
[TBL] [Abstract][Full Text] [Related]
5. Influence of exercise on plasma concentrations of isosorbide dinitrate.
Bogaert MG; Lefebvre RA; Rosseel MT; Bouckaert J
Eur J Clin Pharmacol; 1988; 35(2):213-5. PubMed ID: 3191942
[TBL] [Abstract][Full Text] [Related]
6. Fate of isosorbide dinitrate and mononitrates in patients with renal failure.
Bogaert MG; Rosseel MT; Boelaert J; Daneels R
Eur J Clin Pharmacol; 1981; 21(1):73-6. PubMed ID: 7333349
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of isosorbide dinitrate and its mononitrates in human plasma by capillary column GLC.
Rosseel MT; Bogaert MG
J Pharm Sci; 1979 May; 68(5):659-60. PubMed ID: 430513
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects.
Chasseaud LF; Down WH; Grundy RK
Eur J Clin Pharmacol; 1975 Apr; 8(3-4):157-60. PubMed ID: 1233213
[TBL] [Abstract][Full Text] [Related]
9. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
Straehl P; Galeazzi RL; Soliva M
Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.
Schneider W; Menke G; Heidemann R; Satter P; Kaltenbach M; Rietbrock N
Eur J Clin Pharmacol; 1990; 38(2):145-7. PubMed ID: 2338111
[TBL] [Abstract][Full Text] [Related]
11. [Concentration-time profile of isosorbide dinitrate and its metabolites in plasma following percutaneous resorption of a transdermal therapeutic system].
Menke G; Schnellhammer R; Rietbrock N
Arzneimittelforschung; 1987 Nov; 37(11):1301-3. PubMed ID: 3440041
[TBL] [Abstract][Full Text] [Related]
12. Fate of orally given isosorbide dinitrate in man: factors of variability.
Bogaert MG; Rosseel MT
Z Kardiol; 1983; 72 Suppl 3():11-3. PubMed ID: 6141676
[TBL] [Abstract][Full Text] [Related]
13. Isosorbide 5-mononitrate pharmacokinetics in humans.
Taylor T; Chasseaud LF; Major R; Doyle E; Darragh A
Biopharm Drug Dispos; 1981; 2(3):255-63. PubMed ID: 7295882
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of organic nitrates.
Bogaert MG
Clin Pharmacokinet; 1983; 8(5):410-21. PubMed ID: 6414751
[TBL] [Abstract][Full Text] [Related]
15. Determination of isosorbide dinitrate and its mononitrate metabolites in human plasma using Extrelut purification and capillary column gas-liquid chromatography.
Santoni Y; Rolland PH; Cano JP
J Chromatogr; 1984 Mar; 306():165-72. PubMed ID: 6715456
[TBL] [Abstract][Full Text] [Related]
16. A simple and sensitive gas chromatography method for determination of isosorbide dinitrate and its metabolites in human plasma: application to pharmacokinetics study on oral spray.
Jiang Z; Wei C; Sun Z; Guo J; Li R; Zhang R; Yuan G; Guo R
Drug Res (Stuttg); 2014 Feb; 64(2):73-8. PubMed ID: 23904215
[TBL] [Abstract][Full Text] [Related]
17. Saliva concentrations of isosorbide dinitrate, isosorbide 2-mononitrate and isosorbide 5-mononitrate.
Taylor IW; Major RM; Chasseaud LF; Taylor T
Br J Clin Pharmacol; 1984 May; 17(5):585-7. PubMed ID: 6733004
[TBL] [Abstract][Full Text] [Related]
18. Contribution of isosorbide-5-mononitrate, a major metabolite of isosorbide dinitrate (ISDN), to the hemodynamic effect of ISDN administered orally in conscious dogs.
Kogi K; Satoh T
Jpn J Pharmacol; 1987 Jul; 44(3):249-57. PubMed ID: 3656782
[TBL] [Abstract][Full Text] [Related]
19. [Plasma levels of isosorbide dinitrate and its metabolites during intravenous infusion in surgical patients--effect of preoperative administration of isosorbide dinitrate].
Murakawa T; Hashimoto Y; Sato T; Takagi H; Kushikata T; Araki I; Kou H; Kimura F; Matsuki A
Masui; 1993 Feb; 42(2):225-32. PubMed ID: 8437354
[TBL] [Abstract][Full Text] [Related]
20. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
Geigenberger A; Degen J; Maier-Lenz H
Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
